MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
批准号:
6512980
负责人:
Antonio Giordano
金额:
$30.51万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-05-01 至 2003-06-30
关键词:
Retroviridae carcinogenesis cell cycle cell growth regulation cell line flow cytometry gene expression gene mutation hamsters human tissue lung neoplasms neoplasm /cancer genetics neoplastic process oncoproteins phosphorylation protein structure function retinoblastoma protein transfection transfection /expression vector tumor suppressor genes virus protein
中文摘要
视网膜母细胞瘤基因家族目前由三个成员组成:pRb,
P107和pRb2/p130,它们共享一个称为
“口袋”结构。口袋区域是许多已知的
与特定功能相关的蛋白质-蛋白质相互作用
这些分子都参与其中。所有三个家庭成员都被证明
BE抑制生长的核磷蛋白的磷酸化状态
是以细胞周期依赖的方式调节的。各自的异位表达
家族成员的死亡导致敏感细胞的G1期生长停滞。这个
Rb家族在抑制增殖中的重要性就是证据
由一些致癌的人类DNA病毒编码的必要性
癌蛋白(E1a、T抗原和E7)可以有效地结合和
隔离RB-家族成员以诱导转化的表型
被感染的细胞。发现人类Prb2/p130基因位于16q12.2区域
在几个人类肿瘤中被删除。PRb2/p130被认为与
包括肺癌在内的几种人类癌症的发病机制和进展
提示pRb2/p130基因可能是肿瘤抑制基因
就像RB一样。然而,尽管它们有许多相似之处,但它正在成为
越来越清楚的是,即使RB家族成员可能能够
它们是相辅相成的,在功能上并不完全多余。每一个
RB家族成员与DISTINCT的功能相关并对其进行调节
时间调控的E2F转录因子家族成员
时间表。T98G人脑胶质母细胞瘤细胞株对
PRb和p107的作用,但从pR2/p130经历生长停滞,
表明pRb2/p130不仅仅是pRb或p107的替代品
在特定的机制上有根本的不同
三个家庭成员使用的生长抑制。另外,
与pRb不同,pRb2/p130的磷酸化形式是首选靶标
DNA肿瘤病毒癌蛋白E1a的差异,表明不同的
机制可能是pRb2/p130功能调节的基础
证明人们不能使用RB模型来推测
PRb2/p130磷酸化的意义及调控。的目标
这项建议如下:
A.为了定义pRb2/p130使用的生长抑制机制(S),
B.为了了解pRb2/p130磷酸化的调节功能,
C.确定Rb2/p130基因在人类肺癌中的作用
发展和进步,
D.制备体内研究pRB2/p130的病毒模型。
英文摘要
The retinoblastoma gene family currently consists of three members: pRb,
p107, and pRb2/p130, that share a particular functional domain termed the
"pocket" structure. The pocket region is responsible for many of the known
specific functionality relevant protein-protein interactions in which
these molecules are involved. All three family members have been shown to
be growth suppressive nuclear phosphoproteins whose phosphorylation status
is regulated in a cell cycle dependent manner. Ectopic expression of each
of the family members leads to G1-growth arrest of sensitive cells. The
importance of the Rb family in the inhibition of proliferation is evidence
by the necessity of a number of oncogenic human DNA viruses to encode
oncoproteins (E1A, T-antigen, and E7) which can effectively bind and
sequester the Rb-family members to elicit a transformed phenotype in
infected cells. The human Prb2/p130 gene maps to 16q12.2, a region found
deleted in several human neoplasia. pRb2/p130 has been implicated in the
pathogenesis and progression of several human cancers, including lung
cancer, suggesting that the pRb2/p130 gene may be a tumor suppressor gene
like RB. Despite their many similarities, however, it is becoming
increasingly clear that even though the Rb family members may be able to
complement each other, they are not fully functionally redundant. Each of
the Rb family members associate with and modulate the function of distinct
members of the E2F transcription factor family in a temporally modulated
schedule. The T98G human glioblastoma cell line is refractory to the
effects of pRb and p107 but undergoes growth arrest from pR2/p130,
indicating the pRb2/p130 is not merely a surrogate for either pRb or p107
and that there are fundamental differences in the specific mechanisms of
growth inhibition employed by the three family members. Additionally,
unlike pRb, the phosphorylated form of pRb2/p130 is the preferred target
of the DNA tumor viral oncoprotein E1A, suggesting that a different
mechanism may underlie the functional regulation of pRb2/p130 and
demonstrating that one can not use the Rb model to speculate the
significance and regulation of phosphorylation of pRb2/p130. The goals of
this proposal are thus:
a. To define the growth inhibitory mechanism(s) employed by pRb2/p130,
b. To understand the regulatory function of pRb2/p130 phosphorylation,
c. To define the role of the Rb2/p130 gene in human lung cancer
development and progression,
d. To prepare viral models for studying pRB2/p130 in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TUMOR SUPPRESSOR RB FAMILY/PRB2 IN MEDULLOBLASTOMA
-
批准号:6825071
-
项目类别:
-
资助金额:$25.98万
-
财政年份:2003
-
负责人:Antonio Giordano
-
依托单位:
Interaction between HIV-1 and cell cycle proteins
-
批准号:6594793
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2002
-
负责人:Antonio Giordano
-
依托单位:
Interaction between HIV-1 and cell cycle proteins
-
批准号:6608078
-
项目类别:
-
资助金额:$15.05万
-
财政年份:2002
-
负责人:Antonio Giordano
-
依托单位:
MOLECULAR CHARACTERIZATION OF A MEMBER OF THE RB FAMILY
-
批准号:6499786
-
项目类别:
-
资助金额:$29.68万
-
财政年份:2001
-
负责人:Antonio Giordano
-
依托单位:
MOLECULAR CHARACTERIZATION OF A MEMBER OF THE RB FAMILY
-
批准号:6348980
-
项目类别:
-
资助金额:$22.46万
-
财政年份:2000
-
负责人:Antonio Giordano
-
依托单位:
MOLECULAR CHARACTERIZATION OF A MEMBER OF THE RB FAMILY
-
批准号:6203211
-
项目类别:
-
资助金额:$22.46万
-
财政年份:1999
-
负责人:Antonio Giordano
-
依托单位:
MOLECULAR CHARACTERIZATION OF A MEMBER OF THE RB FAMILY
-
批准号:6102761
-
项目类别:
-
资助金额:$22.46万
-
财政年份:1998
-
负责人:Antonio Giordano
-
依托单位:
ROLE OF RB FAMILY IN JC VIRUS INDUCED GLIOBLASTOMA
-
批准号:6273945
-
项目类别:
-
资助金额:$19.18万
-
财政年份:1998
-
负责人:Antonio Giordano
-
依托单位:
ROLE OF RB FAMILY IN JC VIRUS INDUCED GLIOBLASTOMA
-
批准号:6243927
-
项目类别:
-
资助金额:$18.96万
-
财政年份:1997
-
负责人:Antonio Giordano
-
依托单位:
MOLECULAR CHARACTERIZATION OF A MEMBER OF THE RB FAMILY
-
批准号:6237267
-
项目类别:
-
资助金额:$22.03万
-
财政年份:1997
-
负责人:Antonio Giordano
-
依托单位:
PRB2--A NOVEL TARGET FOR THE AD5 E1A ONCOPROTEINS
-
批准号:2101768
-
项目类别:
-
资助金额:$24.59万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
-
批准号:6172136
-
项目类别:
-
资助金额:$30.96万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
pRb2/p130: from the mechanisms to gene therapy
-
批准号:7225910
-
项目类别:
-
资助金额:$32.11万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
PRB2--A NOVEL TARGET FOR THE AD5 E1A ONCOPROTEINS
-
批准号:2101769
-
项目类别:
-
资助金额:$25.09万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
-
批准号:2696328
-
项目类别:
-
资助金额:$29.7万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
-
批准号:2895060
-
项目类别:
-
资助金额:$30.48万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
pRb2/p130: from the mechanisms to gene therapy
-
批准号:7088926
-
项目类别:
-
资助金额:$33.07万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
PRB2--A NOVEL TARGET FOR THE AD5 E1A ONCOPROTEINS
-
批准号:2101767
-
项目类别:
-
资助金额:$22.07万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
pRb2/p130: from the mechanisms to gene therapy
-
批准号:6908896
-
项目类别:
-
资助金额:$33.86万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
MODULATION OF PRB2/P130 MEDIATED GROWTH SUPPRESSION
-
批准号:6376025
-
项目类别:
-
资助金额:$31.89万
-
财政年份:1994
-
负责人:Antonio Giordano
-
依托单位:
海外基金